Scrabble gets super-sized, personal
DANVERS, Mass. Winning Moves Games is set to delight board game fans with its two newest versions of the Scrabble game.
Scrabble Me and Super Scrabble combine the traditional game play of one of the top-selling board games of all-time with enhanced game boards and scoring experiences, the company said.
In Scrabble Me, players build words on their own individual boards (up to four) simultaneously. The “prize tile podium” makes play more dynamic and gives players a chance to choose some face-up tiles in addition to the traditional blind draw from the letter bag. Original rules of scoring, letter placement and legal word play are followed.
In Super Scrabble, however, players use 200 letters (100 more than the original Scrabble game) and a larger game board featuring quadruple letter and word scoring opportunities. This Scrabble game is super-sized, with three extra rows for a larger playing space. Super Scrabble also comes in a “Deluxe” edition, equipped with a rotating game board and raised grid spaces for simple piece-placing. Both games also come with a guide book detailing the history of Scrabble and the official rules.
“Scrabble has been popular for more than 70 years, and Scrabble fans are passionate about the way the game is played,” said Phil Orbanes, founder of Winning Moves Games. “Scrabble Me and Super Scrabble are great examples of how games can change subtly while maintaining the core principles that have made Scrabble one of the best games for decades.”
Supervalu amends, extends revolving credit facility
MINNEAPOLIS Supervalu on Monday announced the successful completion of its previously announced plan to amend and extend the revolving credit facility and a portion of its term facility under its secured credit agreement.
Pamela Knous, Supervalu CFO, stated, “Completing this amendment and reducing total debt in the past fiscal year by approximately $850 million, which exceeded our goal of $700 million, represent important milestones toward ensuring our future liquidity.”
The amended credit facility is comprised of the following extended tranches with updated pricing — $1.5 billion of revolving credit expiring April 5, 2015 and $500 million of term loan B maturing Oct. 5, 2015.
Peter Ciano named Tris Pharma’s VP corporate development
MONMOUTH JUNCTION, N.J. A specialty pharmaceutical company that develops innovative drug delivery technologies has appointed a new VP corporate development.
Tris Pharma said Peter Ciano, who currently is a business development consultant for the company, now will lead and manage Tris’ lead all commercial efforts including business development, licensing, identifying growth opportunities and deal executions for its brand side of the business.
“As our technology gains wider acceptance for both Rx and OTC branded businesses, we are increasingly faced with the need for intelligent pursuit of the products and opportunities. Peter’s solid analytical approach coupled with his deep understanding of pharmaceutical marketer’s needs and health care provider’s requirement for reimbursement makes him uniquely qualified to guide and lead Tris in this position,” said Ketan Mehta, founder and CEO of Tris Pharma.
Prior to joining Tris, Ciano worked at Kos Pharmaceuticals (prior to its acquisition by Abbott) for nearly six years, including two years as its executive director of corporate development and business planning.
Most recently, Tris had announced FDA had approval two NDAs including first-ever 24-hour ER suspension. Tris has an active portfolio of more than 20 OTC and Rx products based on its proprietary technology.